XTalks

MAY 2, 2024

Several common themes included the integration of technology like blockchain and AI in food safety, the importance of a well-trained workforce and the continuous need for industry collaboration. Chris Bowman, President of Sesotec , discussed the application of AI in enhancing the sensitivity of metal detectors used in food safety.

Compliance 108

Compliance Regulation Production Containment 108

Pharmaceutical Technology

JUNE 29, 2022

This year has already been eventful when it comes to the development of therapies for rare diseases. Most, if not all, of these therapies used the FDA’s Orphan Drug Designation to aid their development plans. So far this year, 176 drugs have already received this designation.

Drugs 246

Drugs FDA Approval Marketing Development 246

Intouch Solutions

APRIL 11, 2024

It has continually evolved, embracing new technologies and methodologies to improve drug discovery, development, and distribution. Pre-Clinical : Deeper comprehension of the impacts and outcomes associated with a particular drug. Precision engagement is a data-driven approach developed for marketing and sales needs.

Compliance 52

Compliance Marketing Drugs Pharma Companies 52

pharmaphorum

APRIL 26, 2021

Technology firm Jolly Good and Teijin Pharma have begun a partnership to develop virtual reality digital therapeutics (VR DTx) for major depressive disorder. Jolly Good is a medical technology company that develops VR solutions and AI-based medical and welfare services that analyse user behaviour in the VR space.

Development 120

Development Medicine Production Marketing 120

XTalks

DECEMBER 21, 2022

This included greater adoption and acceptance of decentralized clinical trial models, emphasis on patient-centric approaches in trials, growing digitization of healthcare and dealing with drug manufacturing challenges. The majority of gene therapies approved and under development are in the areas of oncology and rare disease.

Life Science 52

Life Science Gene Therapy Gene Clinical Trials 52

XTalks

FEBRUARY 27, 2024

There have been significant advancements in new rare disease drugs, particularly for genetic disorders that can be treated by correcting, replacing or silencing defective genes. The US Food and Drug Administration (FDA) has approved a number of new rare disease drugs in recent years, including gene therapies.

Research 59

Research Drugs Gene Therapy Clinical Trials 59

Drug Discovery World

OCTOBER 3, 2022

A series of short seminars focused on automation and technology will be available to visitors at Drug Discovery 2022 which takes place at the ExCel, London 4 and 5 October. will discuss The role of AI and Automation in Personalised Medicine: How can AI Help in the Post- Drug Discovery Process. Fellowship Programme.

Drugs 52

Drugs Scientist Bioinformatics Medicine 52